Intranasal LPS-mediated Parkinson's model challenges the pathogenesis of nasal cavity and environmental toxins.
Accumulating evidence implicates the relationship between neuroinflammation and pathogenesis in idiopathic Parkinson's disease (iPD). The nose has recently been considered a gate way to the brain which facilitates entry of environmental neurotoxin into the brain. Our study aims to build a PD mo...
Main Authors: | Qing He, Wenbo Yu, Jianjun Wu, Chan Chen, Zhiyin Lou, Qiong Zhang, Jian Zhao, Jian Wang, Baoguo Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3826714?pdf=render |
Similar Items
-
Effects of intranasal medicines on microcirculatory blood flow of nasal cavity
by: Svistunov A.A., et al.
Published: (2012-09-01) -
Intranasal Tooth - An Ectopic Eruption of Mesiodens in Nasal Cavity: A Case Report and Review
by: R Guru Prasad, et al.
Published: (2011-01-01) -
Invaplex functions as an intranasal adjuvant for subunit and DNA vaccines co-delivered in the nasal cavity of nonhuman primates
by: Jeremy V. Camp, et al.
Published: (2021-08-01) -
The study of intranasal liposome-inactived NDV vaccine with LPS
by: Kuo-Ming Lee, et al.
Published: (2007) -
Correlation between mitochondrial dysfunction and the pathogenesis of Parkinson's disease
by: Xiao-yu LIU, et al.
Published: (2014-02-01)